ConductScience.org, home

Paper39699210

Population pharmacokinetics of piperacillin-tazobactam in the plasma and cerebrospinal fluid of critically ill patients.

Kumta N and 11 others. Antimicrob Agents Chemother, 2025. Cited by 3 papers, by iCite.

Cite this record

ConductScience Library. Population pharmacokinetics of piperacillin-tazobactam in the plasma and cerebrospinal fluid of critically ill patients. Papers, record 39699210. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39699210

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Population pharmacokinetics of piperacillin-tazobactam in the plasma and cerebrospinal fluid of critically ill patients.
PubMed
Journal
Antimicrob Agents Chemother
PubMed
Year
2025
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
3
iCite
Revised in PubMed
2025-08-25
PubMed

Authors12

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Kumta NNileshhttps://orcid.org/0000-0002-9272-342X
2Heffernan AJAaron Jhttps://orcid.org/0000-0002-7929-9812
3Cotta MOMenino Osberthttps://orcid.org/0000-0002-2058-2314
4Liu XXin
5Parker SSuzannehttps://orcid.org/0000-0002-6124-7475
6Wallis SSteven
7Livermore AAmelia
8Starr TTherese
9Wong WTWai Tat
10Joynt GMGavin M
11Lipman JJeffrey
12Roberts JAJason Ahttps://orcid.org/0000-0001-6218-435X

Source PubMed

Download CSV of authors

Topics13

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Piperacillin, Tazobactam Drug CombinationMajor topic
Anti-Bacterial AgentsMajor topic
Cerebral VentriculitisMajor topic
Humans
Female
Middle Aged
Critical Illness
Male
Aged
Piperacillin
Adult
Tazobactam
Microbial Sensitivity Tests

Source PubMed

Download CSV of topics

Grants2

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
Intensive Care Foundation (ICF)PubMed
Royal Brisbane and Women's Hospital Foundation (RBWH Foundation)PubMed

Source PubMed

Download CSV of grants

References35

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
117485505Systematic comparison of the population pharmacokinetics and pharmacodynamics of piperacillin in cystic fibrosis patients and healthy volunteers.Antimicrob Agents Chemother2007https://conductscience.org/library/papers/17485505PubMed
225219657Meta-analysis identifies tumor necrosis factor-alpha and interleukin-1 beta as diagnostic biomarkers for bacterial and aseptic meningitis.Curr Neurovasc Res2014https://conductscience.org/library/papers/25219657PubMed
38383655The chemistry, pharmacokinetics and tissue distribution of piperacillin/tazobactam.J Antimicrob Chemother1993https://conductscience.org/library/papers/8383655PubMed
424752260Population pharmacokinetic analysis of piperacillin in burn patients.Antimicrob Agents Chemother2014https://conductscience.org/library/papers/24752260PubMed
512205070Pharmacodynamics of cefepime in patients with Gram-negative infections.J Antimicrob Chemother2002https://conductscience.org/library/papers/12205070PubMed
618313273Evaluation of area under the inhibitory curve (AUIC) and time above the minimum inhibitory concentration (T>MIC) as predictors of outcome for cefepime and ceftazidime in serious bacterial infections.Int J Antimicrob Agents2008https://conductscience.org/library/papers/18313273PubMed
735625262Comparison of Piperacillin and Tazobactam Pharmacokinetics in Critically Ill Patients with Trauma or with Burn.Antibiotics (Basel)2022https://conductscience.org/library/papers/35625262PubMed
828905331Antibiotic Distribution into Cerebrospinal Fluid: Can Dosing Safely Account for Drug and Disease Factors in the Treatment of Ventriculostomy-Associated Infections?Clin Pharmacokinet2018https://conductscience.org/library/papers/28905331PubMed
930589457Pharmacokinetics and Pharmacodynamics of β-Lactamase Inhibitors.Pharmacotherapy2019https://conductscience.org/library/papers/30589457PubMed
1029385448Comparison of piperacillin exposure in the lungs of critically ill patients and healthy volunteers.J Antimicrob Chemother2018https://conductscience.org/library/papers/29385448PubMed
1125632974Are standard doses of piperacillin sufficient for critically ill patients with augmented creatinine clearance?Crit Care2015https://conductscience.org/library/papers/25632974PubMed
1230707668Mean Body Weight, Height, Waist Circumference, and Body Mass Index Among Adults: United States, 1999-2000 Through 2015-2016.Natl Health Stat Report2018https://conductscience.org/library/papers/30707668PubMed
1325567583A meta-analysis of ventriculostomy-associated cerebrospinal fluid infections.BMC Infect Dis2015https://conductscience.org/library/papers/25567583PubMed
1434600447Diagnostic value of cerebrospinal fluid levels of D-lactate, tumour necrosis factor-alpha and interleukin-6, -8, and -17 in suspected nosocomial meningitis.Singapore Med J2024https://conductscience.org/library/papers/34600447PubMed
1527736759Pharmacokinetics of Piperacillin in Critically Ill Australian Indigenous Patients with Severe Sepsis.Antimicrob Agents Chemother2016https://conductscience.org/library/papers/27736759PubMed
1630289173Beta-lactam-induced severe neutropaenia: a descriptive study.Fundam Clin Pharmacol2019https://conductscience.org/library/papers/30289173PubMed
1724768475Individualised antibiotic dosing for patients who are critically ill: challenges and potential solutions.Lancet Infect Dis2014https://conductscience.org/library/papers/24768475PubMed
1825643277Applying pharmacokinetic/pharmacodynamic principles in critically ill patients: optimizing efficacy and reducing resistance development.Semin Respir Crit Care Med2015https://conductscience.org/library/papers/25643277PubMed
1928052849Population Pharmacokinetics of Piperacillin in Nonobese, Obese, and Morbidly Obese Critically Ill Patients.Antimicrob Agents Chemother2017https://conductscience.org/library/papers/28052849PubMed
2024429437DALI: defining antibiotic levels in intensive care unit patients: are current β-lactam antibiotic doses sufficient for critically ill patients?Clin Infect Dis2014https://conductscience.org/library/papers/24429437PubMed

See all 35 referencesDownload CSV of references

Cited by2

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3 citations.

PMIDTitleJournalYearIn PapersSource
42318924
A multicentre evaluation of pharmacokinetic/pharmacodynamic target attainment of piperacillin and tazobactam and the association with clinical outcomes in critically ill patients with sepsis and septic shock.
J Antimicrob Chemother2026https://conductscience.org/library/papers/42318924PubMed
41310458Clinical characteristics and management of Listeria monocytogenes meningitis in children beyond the neonatal stage: a 10 years retrospective study.BMC Infect Dis2025https://conductscience.org/library/papers/41310458PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39699210

GET https://conductscience.org/api/papers/v1/39699210/references?page=2